drugset / Trial / NCT00163267

Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel

NCT00163267

Phase 2/3 Completed 80 enrolled University Hospital Tuebingen
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The Mirror Study is a randomized, double-blinded mono-centre trial the access the periinterventinal and postinterventional administration of clopidogrel in patients with peripheral vascular disease.

Timeline

Start
2005-09
Primary completion
2009-12
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule